In Vitro and In Vivo Evaluation of Zinc-Modified Ca-Si-Based Ceramic Coating for Bone Implants

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Yu, Jiangming ^a   Li, Kai ^b   Zheng, Xuebin ^b   He, Dannong ^c   Ye, Xiaojian ^a   Wang, Meiyan ^c  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF CERAMICS   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; BIOMATERIAL; CALCIUM SILICATE; HARDYSTONITE; MESSENGER RNA; OSTEOCALCIN; PROCOLLAGEN; PROCOLLAGEN ALPHA 1; SOMATOMEDIN C; TITANIUM; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCOMPATIBILITY; BONE CONDUCTION; BONE IMPLANT; BONE REGENERATION; CANCER CELL CULTURE; CELL ADHESION; CELL DIFFERENTIATION; CELL PROLIFERATION; CERAMIC PROSTHESIS; CONTROLLED STUDY; FEMUR MALFORMATION; HISTOPATHOLOGY; IN VITRO STUDY; IN VIVO STUDY; MALE; MOLECULAR STABILITY; MORPHOMETRICS; MOUSE; NONHUMAN; OSTEOBLAST; RABBIT;

ALKALINE PHOSPHATASE; ANIMALS; BONE AND BONES; CALCIFICATION, PHYSIOLOGIC; CALCIUM; CELL ADHESION; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELL SHAPE; CERAMICS; COATED MATERIALS, BIOCOMPATIBLE; GENE EXPRESSION REGULATION; MICE; OSTEOBLASTS; OSTEOCALCIN; PROSTHESES AND IMPLANTS; PROSTHESIS IMPLANTATION; RABBITS; SILICON; ZINC;

EID: 84874604303     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0057564     Document Type: Article

References (51)

1. Siriphannon P, Kameshima Y, Yasumori A, Okada K, Hayashi S, (2000) Influence of preparation conditions on the microstructure and bioactivity of α-CaSiO3 ceramics: Formation of hydroxyapatite in simulated body fluid. J Biomed Mater Res 52: 30-39.
2. Ni SY, Chang J, Chou L, Zhai WY, (2007) Comparison of osteoblast-like cell responses to calcium silicate and tricalcium phosphate ceramics in vitro. J Biomed Mater Res Part B 80B: 174-183.
3. Xue W, Liu X, Zheng X, Ding C, (2005) In vivo evaluation of plasma-sprayed wollastonite coating. Biomaterials 26: 3455-3460.
4. Siriphannon P, Kameshima Y, Yasumori A, Okada K, Hayashi S, (2002) Formation of hydroxyapatite on CaSiO3 powders in simulated body fluid. J European Ceram Soc 22: 511-520.
5. Wu C, Ramaswamy Y, Soeparto A, Zreiqat H, (2008) Incorporation of titanium into calcium silicate improved their chemical stability and biological properties. J Biomed Mater Res Part A. 86A: 402-410.
6. Liu XY, Chu PK, Ding CX, (2004) Surface modification of titanium, titanium alloys, and related materials for biomedical applications. Mater Sci Eng R-Rep 47: 49-121.
7. Liu XY, Ding CX, Wang ZY, (2001) Apatite formed on the surface of plasma-sprayed wollastonite coating immersed in simulated body fluid. Biomaterials 22: 2007-2012.
8. Liu XY, Ding CX, Chu PK, (2004) Mechanism of apatite formation on wollastonite coatings in simulated body fluids. Biomaterials 25: 1755-1761.
9. Sun LM, Berndt CC, Gross KA, Kucuk A, (2001) Material fundamentals and clinical performance of plasma-sprayed hydroxyapatite coatings: A review. J Biomed Mater Res 58: 570-592.
10. Liu XY, Tao SY, Ding CX, (2002) Bioactivity of plasma sprayed dicalcium silicate coatings. Biomaterials 23: 963-968.
11. Wu CT, Chang JA, Wang JY, Ni SY, Zhai WY, (2005) Preparation and characteristics of a calcium magnesium silicate (bredigite) bioactive ceramic. Biomaterials 26: 2925-2931.
12. Ramaswamy Y, Wu CT, Zhou H, Zreiqat H, (2008) Biological response of human bone cells to zinc-modified Ca-Si-based ceramics. Acta Biomater 4: 1487-1497.
13. Lu HX, Kawazoe N, Tateishi T, Chen GP, Jin XG, et al. (2010) In vitro Proliferation and osteogenic differentiation of human bone marrow-derived mesenchymal stem cells cultured with hardystonite (Ca2ZnSi2O7) and β-TCP Ceramics. J Biomater Appl 25: 39-56.
14. Wu CT, Ramaswamy Y, Kwik D, Zreiqat H, (2007) The effect of strontium incorporation into CaSiO3 ceramics on their physical and biological properties. Biomaterials 28: 3171-3181.
15. Ramaswamy Y, Wu C, Van Hummel A, Combes V, Grau G, et al. (2008) The responses of osteoblasts, osteoclasts and endothelial cells to zirconium modified calcium-silicate-based ceramic. Biomaterials 29: 4392-4402.
16. Liu XY, Ding CX, (2002) Plasma sprayed wollastonite/TiO2 composite coatings on titanium alloys. Biomaterials 23: 4065-4077.
17. Liang Y, Xie YT, Ji H, Huang LP, Zheng XB, (2010) Excellent stability of plasma-sprayed bioactive Ca3ZrSi2O9 ceramic coating on Ti-6Al-4V. Appl Surf Sci 256: 4677-4681.
18. Tapiero H, Tew KD, (2003) Trace elements in human physiology and pathology: zinc and metallothioneins. Biomed Pharmacother 57: 399-411.
19. Yamaguchi M, Oishi H, Suketa Y, (1987) Stimulatory effect of zinc on bone formation in tissue culture. Biochemical pharmacology 36: 4007-4012.
20. Hsieh HS, Navia JM, (1980) Zinc deficiency and bone formation in guinea pig alveolar implants. J Nutr 110: 1581-1588.
21. Oner G, Bhaumick B, Bala RM, (1984) Effect of zinc deficiency on serum somatomedin levels and skeletal growth in young rats. Endocrinology 114: 1860-1863.
22. Li K, Yu J, Xie Y, Huang L, Ye X, et al. (2011) Chemical stability and antimicrobial activity of plasma sprayed bioactive Ca2ZnSi 2O7)coating. J Mater sci: Mater Med 22: 2781-2789.
23. Anselme K, (2000) Osteoblast adhesion on biomaterials. Biomaterials 21: 667-681.
24. Guleryuz H, Cimenoglu H, (2004) Effect of thermal oxidation on corrosion and corrosion-wear behaviour of a Ti-6A1-4V alloy. Biomaterials 25: 3325-3333.
25. Ma PX, (2008) Biomimetic materials for tissue engineering. Adv Drug Deliv Rev 60: 184-198.
26. Zeng HT, Chittur KK, Lacefield WR, (1999) Analysis of bovine serum albumin adsorption on calcium phosphate and titanium surfaces. Biomaterials 20: 377-384.
27. Sader MS, LeGeros RZ, Soares GA, (2009) Human osteoblasts adhesion and proliferation on magnesium-substituted tricalcium phosphate dense tablets. J Mater Sci: Mater Med 20: 521-527.
28. Benoit DSW, Schwartz MP, Durney AR, Anseth KS, (2008) Small functional groups for controlled differentiation of hydrogel-encapsulated human mesenchymal stem cells. Nat Mater 7: 816-823.
29. Malaval L, Modrowski D, Gupta AK, Aubin JE, (1994) Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone-marrow stromal cell-cultures. J Cell Physiol 158: 555-572.
30. Maddi A, Hai H, Ong ST, Sharp L, Harris M, et al. (2006) Long wave ultrasound may enhance bone regeneration by altering OPG/RANKL ratio in human osteoblast-like cells. Bone 39: 283-288.
31. Habibovic P, Barralet JE, (2011) Bioinorganics and biomaterials: Bone repair. Acta Biomater 7: 3013-3026.
32. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, et al. (2007) Endocrine regulation of energy metabolism by the skeleton. Cell 130: 456-469.
33. Chesters JK, (1998) Molecular biological approaches to nutrient-gene interactions. Proc Nutr Soc 57: 249-256.
34. Cousins RJ, (1998) A role of zinc in the regulation of gene expression. Proc Nutr Soc 57: 307-311.
35. Ito A, Kawamura H, Otsuka M, Ikeuchi M, Ohgushi H, et al. (2002) Zinc-releasing calcium phosphate for stimulating bone formation. Mater Sci Eng C-Biomimetic Supramol Syst 22: 21-25.
36. Kawamura H, Ito A, Miyakawa S, Layrolle P, Ojima K, et al. (2000) Stimulatory effect of zinc-releasing calcium phosphate implant on bone formation in rabbit femora. J Biomed Mater Res 50: 184-190.
37. Ito A, Otsuka M, Kawamura H, Ikeuchi M, Ohgushi H, et al. (2005) Zinc-containing tricalcium phosphate and related materials for promoting bone formation. Curr Appl Phys 5: 402-406.
38. Kwun IS, Cho YE, Lomeda RAR, Shin HI, Choi JY, et al. (2010) Zinc deficiency suppresses matrix mineralization and retards osteogenesis transiently with catch-up possibly through Runx 2 modulation. Bone 46: 732-741.
39. Stein GS, Lian JB, Owen TA, (1990) Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. FASEB J 4: 3111-3123.
40. Franceschi RT, Iyer BS, (1992) Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells. J Bone Miner Res 7: 235-246.
41. Ehara A, Ogata K, Imazato S, Ebisu S, Nakano T, et al. (2003) Effects of α-TCP and TetCP on MC3T3-E1 proliferation, differentiation and mineralization. Biomaterials 24: 831-836.
42. Kimelman N, Pelled G, Helm GA, Huard J, Schwarz EM, et al. (2007) Review: Gene and stem cell based therapeutics for bone regeneration and repair. Tissue Eng 13: 1135-1150.
43. Levenberg S, Huang NF, Lavik E, Rogers AB, Itskovitz Eldor J, et al. (2003) Differentiation of human embryonic stem cells on three-dimensional polymer scaffolds. Proc Natl Acad Sci USA 100: 12741-12746.
44. Richardson TP, Peters MC, Ennett AB, Mooney DJ, (2001) Polymeric system for dual growth factor delivery. Nat Biotechnol 19: 1029-1034.
45. Takahashi T, Ogasawara T, Kishimoto J, Liu GY, Asato H, et al. (2005) Synergistic effects of FGF-2 with insulin or IGF-I on the proliferation of human auricular chondrocytes. Cell Transplant 14: 683-693.
46. Canalis E, Rydziel S, Delany AM, Varghese S, Jeffrey JJ, (1995) Insulin-like growth-factors inhibit interstitial collagenase synthesis in bone cell-cultures. Endocrinology 136: 1348-1354.
47. Hill PA, Reynolds JJ, Meikle MC, (1995) Osteoblasts mediate insulin-like growth-factor-I and growth-factor-II stimulation of osteoclast formation and function. Endocrinology 136: 124-131.
48. Fox SW, Lovibond AC, (2005) Current insights into the role of transforming growth factor-β in bone resorption. Mol Cell Endocrinol 243: 19-26.
49. Janssens K, ten Dijke P, Janssens S, Van Hul W, (2005) Transforming growth factor-β1 to the bone. Endocr Rev 26: 743-774.
50. Yamaguchi M, Hashizume M, (1994) Effect of β-alanyl-L-histidinato zinc on protein-components in osteoblastic MC3T3-El cells increase in osteocalcin, insulin-like growth-factor-I and transforming growth-factor-β. Mol Cell Biochem 136: 163-169.
51. Zreiqat H, Ramaswamy Y, Wu CT, Paschalidis A, Lu ZF, et al. (2010) The incorporation of strontium and zinc into a calcium-silicon ceramic for bone tissue engineering. Biomaterials 31: 3175-3184.